Individual patient level meta-analysis of the performance of the Decipher genomic classifier in high-risk men post-prostatectomy to predict development of metastatic disease.

作者
Daniel Eidelberg Spratt,Kasra Yousefi,Samineh Deheshi,Ashley Evan Ross,Edward Matthew Schaeffer,Bruce J. Trock,Jeffrey R. Karnes,Andrew G. Glass,Robert Benjamin Den,Adam Paul Dicker,Stephen J. Freedland,Lucia L.C. Lam,Marguerite du Plessis,Voleak Choeurng,Zaid Haddad,Christine Buerki,Elai Davicioni,Sheila A. Weinmann,Eric A. Klein,Felix Yi-Chung Feng
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:35 (6_suppl): 133-133 被引量:1
标识
DOI:10.1200/jco.2017.35.6_suppl.133
摘要

133 Background: The genomic classifier, Decipher, has been validated to predict risk of metastasis after radical prostatectomy (RP). However, the cohort size and event rate in the previous studies did not allow for a thorough investigation into performance within individual clinicopathologic or treatment subgroups. In this study, we present the first meta-analysis of the performance of the 22-marker genomic classifier in men with prostate cancer (PCa) post-RP. Methods: MEDLINE, EMBASE, and the Decipher genomic resource information database were searched for published reports of men with PCa treated by RP between 2010 and 2016 where the benefit of the Decipher genomic classifier test was assessed. The primary end point was the ability of Decipher to independently improve prognostication of regional or distant metastasis over routine clinicopathologic factors. Meta-analysis was performed with random-effects modeling, and extent of heterogeneity between studies was determined with the I2 test. Results: Five studies (975 total patients, and 855 with individual patient genomic and clinicopathologic data) were eligible for analysis. The median follow-up was 8 years. All patients had clinical high-risk disease, yet 60.9%, 22.6%, and 16.5% of patients were classified as low, intermediate, and high-risk, respectively by Decipher and had 10-year cumulative incidence rates of metastases of 5.5%, 15.0% and 26.7% (p < 0.001), respectively. Adjusting for standard clinicopathologic variables, on multivariable analysis Decipher remained a statistically significant predictor of metastasis (hazard ratio [HR] 1.30 per 0.1 unit, 95% confidence interval [CI] 1.14-1.47, p < 0.001), and the summary HR for metastasis of Decipher across the 5 studies was 1.52 (95% CI 1.39-1.67) per 0.1 unit. Conclusions: The genomic classifier test, Decipher, has the ability to independently improve prognostication of men post-RP, as well as within nearly all clinicopathologic and treatment subgroups. Strong consideration should be given to incorporating the use of genomic testing in clinical decision making and clinical trials to better individualize treatment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yfn完成签到,获得积分10
1秒前
1秒前
包容映安发布了新的文献求助10
2秒前
2秒前
阿狸完成签到,获得积分10
2秒前
w7完成签到 ,获得积分10
2秒前
隐形曼青的应助被hyfwkd采纳,获得30
2秒前
2秒前
3秒前
3秒前
3秒前
3秒前
PENGQIDU完成签到 ,获得积分10
3秒前
CaliU发布了新的文献求助10
3秒前
捏鱼发布了新的文献求助10
3秒前
荼蘼发布了新的文献求助10
3秒前
4秒前
4秒前
成_顺发布了新的文献求助10
4秒前
5秒前
无题发布了新的文献求助10
5秒前
5秒前
一条小鱼发布了新的文献求助10
6秒前
Abracadabra完成签到,获得积分10
6秒前
6秒前
Sheryl完成签到,获得积分10
7秒前
8秒前
8秒前
8秒前
zxdzaz完成签到 ,获得积分10
8秒前
如意的小鸭子完成签到 ,获得积分10
8秒前
zcx完成签到,获得积分10
9秒前
9秒前
9秒前
方方公主发布了新的文献求助10
10秒前
Lucas的应助被山复尔尔采纳,获得10
10秒前
木田发布了新的文献求助10
10秒前
NexusExplorer的应助被腼腆的雪珊采纳,获得10
11秒前
香蕉觅云的应助被lianxin采纳,获得10
11秒前
NexusExplorer的应助被xucc采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175262
求助须知:如何正确求助?哪些是违规求助? 9567017
关于积分的说明 21789663
捐赠科研通 7769695
什么是DOI,文献DOI怎么找? 3431840
关于科研通互助平台的介绍 2556124
邀请新用户注册赠送积分活动 2477241